Physician profile
Scott T Farber
NPI 1295959948
$2,446.04
in general payments reported to CMS, 2019-2025
9 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $245 · 2021: $120 · 2022: $311 · 2023: $49.79 · 2024: $69.39 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Travel and Lodging: $253 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.66 |
| Travel and Lodging | $252.98 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $858.70 | 2019-2024 | |
| Allergan, INC. | $506.05 | 2019-2022 | |
| Motiva USA, LLC | $500.78 | 2025 | |
| Mentor Worldwide LLC | $227.48 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $106.71 | 2022-2025 | Phasix Mesh |
| Abbvie INC. | $92.55 | 2023-2024 | |
| Tela Bio, INC. | $65.61 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Tepha INC | $53.78 | 2020 | |
| Becton, Dickinson and Company | $34.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.